Financhill
Buy
75

SGHT Quote, Financials, Valuation and Earnings

Last price:
$4.20
Seasonality move :
-3.87%
Day range:
$4.13 - $4.25
52-week range:
$2.03 - $8.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.71x
P/B ratio:
2.79x
Volume:
101.8K
Avg. volume:
181K
1-year change:
-37.37%
Market cap:
$216.6M
Revenue:
$79.9M
EPS (TTM):
-$0.98

Analysts' Opinion

  • Consensus Rating
    Sight Sciences has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of $3.68, Sight Sciences has an estimated downside of -12.09% from its current price of $4.19.
  • Price Target Upside
    According to analysts, the highest upside price target is $5.00 representing 19.33% upside increase from its current price of $4.19.

Fair Value

  • According to the consensus of 8 analysts, Sight Sciences has -12.09% downside to fair value with a price target of $3.68 per share.

SGHT vs. S&P 500

  • Over the past 5 trading days, Sight Sciences has underperformed the S&P 500 by -1.54% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Sight Sciences does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Sight Sciences revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sight Sciences reported revenues of $17.5M.

Earnings Growth

  • Sight Sciences has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Sight Sciences reported earnings per share of -$0.28.
Enterprise value:
147.4M
EV / Invested capital:
1.26x
Price / LTM sales:
2.71x
EV / EBIT:
--
EV / Revenue:
1.89x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-6.10x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$66.9M
Return On Assets:
-34.24%
Net Income Margin (TTM):
-63.24%
Return On Equity:
-52.44%
Return On Invested Capital:
-37.91%
Operating Margin:
-79.16%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $75.3M $81.5M $78.1M $19.3M $17.5M
Gross Profit $62.9M $69.9M $66.9M $16.5M $15.1M
Operating Income -$79.3M -$54.4M -$49.7M -$14.7M -$13.9M
EBITDA -$74.6M -$48.6M -$43.7M -$14.9M -$12.7M
Diluted EPS -$1.66 -$1.12 -$0.98 -$0.33 -$0.28
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $57.5M $255.3M $193.7M $152.1M $126.9M
Total Assets $60.5M $258.6M $196.6M $155.6M $129.7M
Current Liabilities $9.3M $12M $15.1M $11.7M $12.1M
Total Liabilities $161.3M $46.7M $50.3M $46.4M $52.1M
Total Equity -$100.8M $211.9M $146.4M $109.2M $77.6M
Total Debt $32.1M $32.8M $33.5M $33.7M $39.6M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -$71.4M -$39.6M -$24.2M -$9.8M -$11.6M
Cash From Investing -$869K -$782K -$268K -$117K --
Cash From Financing $1M $318K $5.9M -$942K $16K
Free Cash Flow -$72.3M -$40.4M -$24.2M -$9.9M -$11.6M
SGHT
Sector
Market Cap
$216.6M
$33.4M
Price % of 52-Week High
49.59%
47.1%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-37.37%
-36.6%
Beta (5-Year)
--
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $4.12
200-day SMA
Buy
Level $3.94
Bollinger Bands (100)
Buy
Level 2.44 - 3.42
Chaikin Money Flow
Sell
Level -507.1K
20-day SMA
Buy
Level $3.69
Relative Strength Index (RSI14)
Buy
Level 69.53
ADX Line
Buy
Level 33.54
Williams %R
Sell
Level -9.9099
50-day SMA
Buy
Level $3.13
MACD (12, 26)
Buy
Level 0.30
25-day Aroon Oscillator
Buy
Level 76
On Balance Volume
Sell
Level -2.2M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-0.8564)
Sell
CA Score (Annual)
Level (-0.8345)
Buy
Beneish M-Score (Annual)
Level (-3.8554)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.0417)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Stock Forecast FAQ

In the current month, SGHT has received 2 Buy ratings 6 Hold ratings, and 0 Sell ratings. The SGHT average analyst price target in the past 3 months is $3.68.

  • Where Will Sight Sciences Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Sight Sciences share price will drop to $3.68 per share over the next 12 months.

  • What Do Analysts Say About Sight Sciences?

    Analysts are divided on their view about Sight Sciences share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sight Sciences is a Sell and believe this share price will rise from its current level to $3.00.

  • What Is Sight Sciences's Price Target?

    The price target for Sight Sciences over the next 1-year time period is forecast to be $3.68 according to 8 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is SGHT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Sight Sciences is a Hold. 6 of 8 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of SGHT?

    You can purchase shares of Sight Sciences via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sight Sciences shares.

  • What Is The Sight Sciences Share Price Today?

    Sight Sciences was last trading at $4.20 per share. This represents the most recent stock quote for Sight Sciences. Yesterday, Sight Sciences closed at $4.19 per share.

  • How To Buy Sight Sciences Stock Online?

    In order to purchase Sight Sciences stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet or Amazon the Better Buy?
Is Alphabet or Amazon the Better Buy?

Alphabet (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN) are two of the mega-cap…

Why Did Ken Griffin Buy Sweetgreen Stock?
Why Did Ken Griffin Buy Sweetgreen Stock?

In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…

Where Will Planet Labs’ Stock Go Next?
Where Will Planet Labs’ Stock Go Next?

On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
73
OKLO alert for Jun 12

Oklo [OKLO] is down 5.6% over the past day.

Buy
87
SMR alert for Jun 12

NuScale Power [SMR] is down 2.96% over the past day.

Buy
53
PLAY alert for Jun 12

Dave & Buster's Entertainment [PLAY] is up 0.69% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock